The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Proliferation and significance of clinically relevant β‐lactamases
Abstract
Inactivation of β‐lactam antibiotics by β‐lactamases in bacterial infections is associated with some of the most serious infectious disease issues that are currently encountered. The evolution of unique β‐lactamases has resulted in more than 1,300 distinct enzymes that have been identified in natural clinical isolates. Of these enzymes, the most deleterious β‐lactamases are the extended‐spectrum β‐lactamases, or ESBLs, that hydrolyze most penicillins and cephalosporins, and the carbapenemases that may inactivate all β‐lactam classes of drugs. The most prominent ESBLs worldwide are the CTX‐M‐14 and CTX‐M‐15 enzymes. Among enzyme families, the TEM and OXA β‐lactamases exhibit the greatest number of variants. The broad groups of carbapenemases are particularly treacherous, especially the KPC serine carbapenemases and the NDM family of metallo‐β‐lactamases, both of which appear in multidrug‐resistant Gram‐negative pathogens that are often resistant to most classes of antibiotics. Although new β‐lactamase inhibitor combinations are being investigated as a means of controlling infections caused by these organisms, additional approaches are sorely needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotic resistance is ancient
D’Costa, V. M., King, C. E., Kalan, L., Morar, M., Sung, W. W. L., Schwarz, C., Froese, D., Zazula, G., Calmels, F., Debruyne, R., et al. (2011) · Nature · doi:10.1038/nature10388 · Cited by 2,720
Bradford, P. A. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.933-951.2001 · Cited by 2,618
A functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,475
Self-citationGlobal Spread of Carbapenemase-producing Enterobacteriaceae
Nordmann, P., Naas, T., & Poirel, L. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1710.110655 · Cited by 2,378
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
Self-citationJacoby, G. A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-08 · Cited by 2,165
Ambler, R. P. (1980) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1980.0049 · Cited by 1,823
Three Decades of β-Lactamase Inhibitors
Drawz, S. M., & Bonomo, R. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-09 · Cited by 1,709
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Nordmann, P., Cuzon, G., & Naas, T. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70054-4 · Cited by 1,579
An Enzyme from Bacteria able to Destroy Penicillin
ABRAHAM, E. P., & CHAIN, E. (1940) · Nature · doi:10.1038/146837a0 · Cited by 1,333
Tzouvelekis, L. S., Markogiannakis, A., Psichogiou, M., Tassios, P. T., & Daikos, G. L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05035-11 · Cited by 1,191
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
Cantón, R., Akóva, M., Carmeli, Y., Giske, C. G., Glupczynski, Y., Gniadkowski, M., Livermore, D. M., Miriagou, V., Naas, T., Rossolini, G. M., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03821.x · Cited by 883
Evidence of Increasing Antibiotic Resistance Gene Abundances in Archived Soils since 1940
Knapp, C. W., Dolfing, J., Ehlert, P. A. I., & Graham, D. W. (2010) · Environmental Science & Technology · doi:10.1021/es901221x · Cited by 837
Extended-spectrum beta-lactamases
Philippon, A., Labia, R., & Jacoby, G. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.8.1131 · Cited by 767
Antibiotic resistance is prevalent in an isolated cave microbiome
Bhullar, K., Waglechner, N., Pawlowski, A., Koteva, K., Banks, E. D., Johnston, M. D., Barton, H. A., & Wright, G. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034953 · Cited by 736
The emerging NDM carbapenemases
Nordmann, P., Poirel, L., Walsh, T. R., & Livermore, D. M. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.09.005 · Cited by 663
Metallo-β-lactamases: a last frontier for β-lactams?
Cornaglia, G., Giamarellou, H., & Rossolini, G. M. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70056-1 · Cited by 613
Evolution and Dissemination of β-Lactamases Accelerated by Generations of β-Lactam Antibiotics
Medeiros, A. A. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s19 · Cited by 587
Qureshi, Z. A., Paterson, D. L., Potoski, B. A., Kilayko, M. C., Sandovsky, G., Sordillo, E., Polsky, B., Adams-Haduch, J. M., & Doi, Y. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06268-11 · Cited by 559
Metallo‐β‐lactamase structure and function
Palzkill, T. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06796.x · Cited by 505
Walther-Rasmussen, J., & Høiby, N. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki482 · Cited by 495
Bush, K., & Fisher, J. F. (2011) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090110-102911 · Cited by 419
Self-citationIdentification and screening of carbapenemase-producing Enterobacteriaceae
Nordmann, P., Gniadkowski, M., Giske, C. G., Poirel, L., Woodford, N., & Miriagou, V. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03815.x · Cited by 408
Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae
Bush, K. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.09.006 · Cited by 398
Self-citationJaurin, B., & Grundström, T. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.8.4897 · Cited by 390
Extended-Spectrum-β-Lactamase, AmpC, and Carbapenemase Issues
Thomson, K. S. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00219-10 · Cited by 356
Characterization of beta-lactamases
Bush, K. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.3.259 · Cited by 305
Self-citationLivermore, D. M. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.12.012 · Cited by 232
Defining an extended-spectrum β-lactamase
Livermore, D. M. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01857.x · Cited by 222
Bauernfeind, A., Stemplinger, I., Jungwirth, R., Ernst, S., & Casellas, J. M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.2.509 · Cited by 220
Baquero, F., Coque, T. M., & de la Cruz, F. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00013-11 · Cited by 207
Sequence of PSE-2 beta-lactamase
Huovinen, P., Huovinen, S., & Jacoby, G. A. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.1.134 · Cited by 180
Therapeutic Options for Infections with Enterobacteriaceae Producing Carbapenem-Hydrolyzing Enzymes
Falagas, M. E., Karageorgopoulos, D. E., & Nordmann, P. (2011) · Future Microbiology · doi:10.2217/fmb.11.49 · Cited by 167
MEDEIROS, A. A. (1984) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a071942 · Cited by 164
Endimiani, A., DePasquale, J. M., Forero, S. V. C., Pérez, F., Hujer, A. M., Roberts-Pollack, D., Fiorella, P. D., Pickens, N. M., Kitchel, B., Casiano-Colón, A. E., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp327 · Cited by 157
Matthew, M., & Hedges, R. W. (1976) · Journal of Bacteriology · doi:10.1128/jb.125.2.713-718.1976 · Cited by 156
Chong, Y., Ito, Y., & Kamimura, T. (2011) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2011.06.001 · Cited by 150
Status report on carbapenemases: challenges and prospects
Patel, G., & Bonomo, R. A. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.28 · Cited by 146
Barthélémy, M., Péduzzi, J., Bernard, H., Tancrède, C., & Labia, R. (1992) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(92)90121-s · Cited by 136
New β‐lactam–β‐lactamase inhibitor combinations in clinical development
Shlaes, D. M. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12010 · Cited by 130
Hombach, M., Bloemberg, G. V., & Böttger, E. C. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr524 · Cited by 128
Belaaouaj, A., Lapouméroulie, C., Caniça, M. M., Vedel, G., Névot, P., Krishnamoorthy, R., & Paul, G. (1994) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1994.tb07010.x · Cited by 123
Gazin, M., Paasch, F., Goossens, H., & Malhotra‐Kumar, S. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06852-11 · Cited by 122
IRT and CMT β-lactamases and inhibitor resistance
Cantón, R., Morosini, M.-I., Martin, O., de la Maza, S., & de la Pedrosa, E. G. G. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01849.x · Cited by 115
Antibiotic resistance: Origins, evolution, selection and spread
Woodford, N. (1998) · Journal of Hospital Infection · doi:10.1016/s0195-6701(98)90033-0 · Cited by 110
Bush, K. (2012) · Scientific and Technical Review (World Organisation for Animal Health) · doi:10.20506/rst.31.1.2096 · Cited by 104
Self-citationNon-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06
Livermore, D. M., Hope, R., Brick, G., Lillie, M., Reynolds, R., & Surveillance, O. B. O. T. B. W. P. O. R. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn351 · Cited by 102
Six Groups of the OXY β-Lactamase Evolved over Millions of Years in Klebsiella oxytoca
Fèvre, C., Jbel, M., Passet, V., Weill, F., Grimont, P. A. D., & Brisse, S. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3453-3462.2005 · Cited by 100
Mammeri, H., Nordmann, P., Berkani, A., & Eb, F. (2008) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2008.01126.x · Cited by 83
Savard, P., & Perl, T. M. (2012) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283558c17 · Cited by 82
Frase, H., Shi, Q., Testero, S. A., Mobashery, S., & Vakulenko, S. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.011262 · Cited by 75
Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration
Landman, D., Babu, E., Shah, N., Kelly, P., Olawole, O. I., Bäcker, M., Bratu, S., & Quale, J. M. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks063 · Cited by 74
Lascols, C., Hackel, M., Hujer, A. M., Marshall, S. H., Bouchillon, S. K., Hoban, D. J., Hawser, S., Badal, R. E., & Bonomo, R. A. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06115-11 · Cited by 72
Qureshi, Z. A., Paterson, D. L., Pakstis, D. L., Adams‐Haduch, J. M., Sandkovsky, G., Sordillo, E. M., Polsky, B., Peleg, A. Y., Bhussar, M. K., & Doi, Y. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.09.009 · Cited by 68
Moland, E. S., Chong, Y., Thomson, K. S., Larone, D. H., & Hanson, N. D. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01143-06 · Cited by 44
Minor extended-spectrum β-lactamases
Akıncı, E., & Vahaboğlu, H. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.119 · Cited by 22
Fong, J. J., Rosé, L., & Radigan, E. (2012) · Annals of Pharmacotherapy · doi:10.1345/aph.1q473 · Cited by 21
Cited by
Mechanisms of Antibiotic Resistance
Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782
An overview of the antimicrobial resistance mechanisms of bacteria
C Reygaert, W., & Department of Biomedical Sciences, O. U. W. B. S. O. M. (2018) · AIMS Microbiology · doi:10.3934/microbiol.2018.3.482 · Cited by 1,893
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
β-Lactams and β-Lactamase Inhibitors: An Overview
Bush, K., & Bradford, P. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025247 · Cited by 1,412
Self-citationPast and Present Perspectives on β-Lactamases
Bush, K. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01076-18 · Cited by 832
Self-citation
Metadata
- Authors
- Bush, K.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2013-01
- Volume
- 1277
- Issue
- 1
- Pages
- 84-90
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W1536681123
- Cited by
- 337
- References
- 57
- FWCI
- 15.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.